Newswise — Nine new studies leveraging the IRIS® Registry (Intelligent Research in Sight) will be presented this week at the 128th Annual Meeting of the American Academy of Ophthalmology.
Launched in 2014, the IRIS Registry is the nation’s first and largest comprehensive eye disease registry. It currently contains data for over 78.9 million patients.
Some of the studies featured include:
In-person and on-demand presentations
Complications after full-thickness keratoplasty. Results demonstrate high complication rates after corneal transplant surgery in patients younger than 18 years. Session PA016. Lyvia Zhang, DO. Geographic disparities in glaucoma surgery. Analysis suggests that patients living in rural areas have less access to surgical glaucoma treatment than patients in urban areas. Session: PO077. Anagha Lokhande, B.A. Risk factors for rapid increase in cup-to-disc ratio. Risk factors identified in this study included age, race, Medicaid status, smoking, intraocular pressure (IOP), visual impairment, and lack of follow-up. Session: PO078. Dr. Andrew Williams, Results of Vitrectomy for Floaters. Analysis of frequency and side effects of floater resection. Session: PO033. Dr. Lawrence Chan, Nerve Growth Factor Treatment for Neurotrophic Keratopathy. Patients treated with nerve growth factors experience improved vision, regardless of disease severity. Session Dr. Asmar Zidan.
on demand poster
Changes in IOP after stand-alone phacoemulsification result in residual lens fragments. IOP spikes after cataract surgery complicated by residual lens fragments are more likely to occur in men or in patients with high baseline IOP. Session Adam Rothman, MD, IOP Reduction After Switching to Latanoprostene Bunod. Patients with open-angle glaucoma or ocular hypertension experienced a reduction in IOP after switching to latanoprostene bunod session PO339. Constance Okeke, MD, proliferative diabetic retinopathy patient lost to follow-up. Patients who did not present for recommended follow-up examinations were more likely to develop new diabetic retinopathy complications, such as macular edema and vitreous hemorrhage. Session PO595. Rahul Khurana, MD, anti-VEGF intravitreal injections for non-FDA-approved indications. More than 20 percent of patients who received anti-VEGF injections were being treated for non-FDA-approved indications, including retinal neovascularization, cystoid macular degeneration, and retinal edema. Session PO638. Dr. Scott Friedman.
About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world’s largest association of ophthalmologists and surgeons. As a global community of 32,000 physicians, we protect vision and empower lives by setting standards in ophthalmology education and advocating for patients and the public. We innovate and support research to advance our profession and ensure we provide the highest quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, please visit aao.org.
